These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 25617843

  • 1. Prostacyclin receptor expression on platelets of humans with type 2 diabetes is inversely correlated with hemoglobin A1c levels.
    Knebel SM, Sprague RS, Stephenson AH.
    Prostaglandins Other Lipid Mediat; 2015; 116-117():131-5. PubMed ID: 25617843
    [Abstract] [Full Text] [Related]

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 3. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
    Fisch A, Tobusch K, Veit K, Meyer J, Darius H.
    Circulation; 1997 Aug 05; 96(3):756-60. PubMed ID: 9264479
    [Abstract] [Full Text] [Related]

  • 4. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 05; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 5. Internalization and down-regulation of the prostacyclin receptor in human platelets.
    Giovanazzi S, Accomazzo MR, Letari O, Oliva D, Nicosia S.
    Biochem J; 1997 Jul 01; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets.
    Darius H, Veit K, Binz C, Fisch A, Meyer J.
    Agents Actions Suppl; 1995 Jul 01; 45():77-83. PubMed ID: 7536385
    [Abstract] [Full Text] [Related]

  • 8. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM, Strange PG.
    Biosci Rep; 1984 Nov 01; 4(11):941-8. PubMed ID: 6084527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Nov 01; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K, Karsch KR, Weisenberger H, Tidow S, Faul C, Renn W.
    J Am Coll Cardiol; 1986 Aug 01; 8(2):259-66. PubMed ID: 3016061
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV, Grünberg B, Kratzer MA, Lorenz R, Siess W.
    Cardiovasc Drugs Ther; 1995 Aug 01; 9(4):619-29. PubMed ID: 8547213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL.
    J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1021-6. PubMed ID: 2175792
    [Abstract] [Full Text] [Related]

  • 19. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA.
    Prostaglandins; 1997 Jan 01; 53(1):21-35. PubMed ID: 9068064
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H, Michael-Hepp J, Thierauch KH, Fisch A.
    Eur J Pharmacol; 1994 Jun 13; 258(3):207-13. PubMed ID: 7522176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.